I think one of the challenges we have as we think about health funding is, you know, there's a lot that a lot of people would like us to do. There's a lot we would like to do. But there are always going to be limits, and it's a question of how we articulate those limits; how we make those decisions on those limits. But Pharmac is required to work within the limits that it has got and it is doing that.